CRISPR Therapeutics

In News

Cathie Wood Bought More CRISPR Therapeutics Stock 2 Days in a Row. Here's What She Sees in the Biotech Stock. - Yahoo Finance

Yahoo Finance - Oct 18, 2026

Cathie Wood Bought More CRISPR Therapeutics Stock 2 Days in a Row. Here's What She Sees in the Biotech Stock. - The Motley Fool

The Motley Fool - Oct 18, 2026

CRISPR Therapeutics (CRSP) Stock Dropped, So What Is Driving Attention Now? - Simply Wall Street

Simply Wall Street - Oct 15, 2026

Crispr Therapeutics Insider Sold Shares Worth $720,373, According to a Recent SEC Filing - www.marketscreener.com

www.marketscreener.com - Oct 16, 2026

CRISPR Therapeutics (NASDAQ:CRSP) Director Sells 14,514 Shares of Stock - MarketBeat

MarketBeat - Oct 16, 2026

Director exercises options for 30,000 shares and sells 14,514 at CRISPR Therapeutics (CRSP) - Stock Titan

Stock Titan - Oct 16, 2026

Form 4 CRISPR Therapeutics AG: James R. Kasinger (General Counsel and Secretary) For: 13 October - Investing.com Nigeria

Investing.com Nigeria - Oct 16, 2026

CRISPR Therapeutics (CRSP) Stock Looks Rich On Upcoming CTX310 Trial Data - Yahoo Finance

Yahoo Finance - Oct 14, 2026

Tax withholding required CRISPR Therapeutics (CRSP) counsel to sell shares at $49.26 each. - Stock Titan

Stock Titan - Oct 15, 2026

Insider Selling: CRISPR Therapeutics (NASDAQ:CRSP) CEO Sells 4,098 Shares of Stock - MarketBeat

MarketBeat - Oct 15, 2026

Form 4 CRISPR Therapeutics AG: Samarth Kulkarni (Director, CEO) For: 13 October - Investing.com Nigeria

Investing.com Nigeria - Oct 17, 2026

CRISPR Therapeutics AG (CRSP) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance

Yahoo Finance - Oct 16, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment